But just 20.7 % of the comparison group had the same syndrome. Many studies show that clozapine is associated with fat gain, but this is actually the first study to spell it out clozapine’s connect to metabolic syndrome. ‘People who have schizophrenia are recognized to exercise less and have poor diet programs,’ Lamberti said. ‘Those elements donate to metabolic syndrome. We can’t say how much clozapine contributes to metabolic syndrome, but we have demonstrated the high prevalence of the syndrome in those that take clozapine.’ The National Institutes of Health initiated the Clinical Antipsychotic Trials for Intervention Efficiency investigation to determine the comparative performance of several medicines.‘We are confident these systems will contribute materially to GSK’s initiatives in monoclonal antibody structured therapeutics. Other information on the agreement aren’t disclosed.. CSL Behring calls for grant requests through LEAD program CSL Behring, a worldwide innovator in the plasma proteins biotherapeutics market, is calling for grant requests through its Neighborhood Empowerment for Advocacy Development program. The LEAD program awards money to United States patient companies that assist people who have rare illnesses in advocating for continuing access to healthcare and life-saving plasma proteins therapies. Those initiatives include developing primary advocacy and grassroots capabilities and advocating on problems to boost access to care.